Advanced search
Search Results: 28 results for keyword "Traphaco".
Big players join hands in national epidemic prevention campaign
26-02-2020 09:00
The threat caused by the novel coronavirus outbreak has been partly relieved with the engagement of leading prestigious players from the pharmaceutical industry, such as Traphaco.
Pharma firms debate reforms
05-06-2019 19:00
With possible new changes in drug rules involving strict conditions for branded pharmaceutical production on the horizon, multinational corporations might find it harder to attend tenders of high-cost branded drugs. Bich Thuy reports.
Traphaco sets down on path to circular growth
27-05-2019 08:57
As sustainable growth is gaining ground in future development strategies, Vietnam’s second-largest publicly-traded drug maker Traphaco is focusing on developing a green value chain to optimise its operational efficiency and to protect the environment. Vu Thi Thuan, chairwoman of Traphaco, talked with VIR’s Bich Thuy the impressive green journey.
Top pharma groups to rethink strategies after sluggish 2018
08-05-2019 20:00
After a tough 12 months, with Vietnamese pharmaceutical giants continuing to report poor business performance in the first quarter of 2019, new solutions are being sought in order to hold firm amid increasingly mounting competition from international rivals. Bich Thuy reports.
Pharma firms look to future
29-03-2019 11:00
With expected fierce rivalry as a result of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership, domestic Vietnamese pharmaceutical businesses are increasingly investing big in technological innovations that help them stay competitive in a lucrative market.
Traphaco fares poorly in optimising profit through financial tools
13-03-2019 16:12
One of the major pharmaceutical firms in the country, Traphaco JSC seems to have forgotten the strength of financial vehicles to realise its profit optimisation target.
Competition intensifies in pharmaceutical sector
30-01-2019 09:44
After a tough 12 months, competition in Vietnam’s lucrative pharmaceutical industry is forecast to heat up in 2019, with domestic and international players in a race to reap the benefits from local policies and new free trade agreements. Bich Thuy reports.
Foreign shareholders nominated for Traphaco management board
07-07-2018 18:10
Two foreign shareholders of Traphaco Joint Stock Company, Super Delta Pte., Ltd. and Magbi Fund Limited, want to add two Koreans to the board of directors of Traphaco.
Traphaco and Cadivi fined for tax arrears
27-06-2018 21:59
The Hanoi Department of Taxation has just issued a fine of nearly VND1 billion ($44,000) to Traphaco JSC (code: TRA) and VND5.5 billion ($242,300) to Vietnam Electric Cable Corporation (Cadivi, code: CAV) for erroneous tax declaration.
Mekong Capital plans to divest from Traphaco
18-08-2017 15:32
It is only a matter of time until Mekong Capital divests its capital in Traphaco JSC (HOSE: TRA), however, the details of its divestment plan remain unclear.
Traphaco just the right medicine for the market
30-03-2013 16:36
Traphaco has grown into the second largest pharmaceutical firm in Vietnam with a sharp network expansion and core business strategy.
VAF confidently looks to 2011
28-02-2011 09:00
The investment environment is likely to favour equity investment funds in blue chip companies. Chris Freund, managing partner of Mekong Capital, tells VIR about the investment opportunities of its Vietnam Azalea Fund (VAF) in 2011.
Mekong Capital triples ownership in Traphaco
26-01-2011 17:35
Mekong Capital announced today that its Vietnam Azalea Fund Limited had tripled its ownership in traditional medicines producer Traphaco Joint Stock Company, increasing its shareholding percentage to 20 per cent from 6.5 per cent.
Mobile Version